Triple GIP/GLP-1/Glucagon receptor agonist. Independently verified at 99.58–99.81% across all vial sizes.
Human Growth Hormone, verified 191AA sequence. Tested at 98.15–98.44% purity. Batch H/2026/02.
Long R3 Insulin-like Growth Factor. Highest-spec 100mcg vials verified at 99.73% purity. Premium grade.
Selective GHRP with minimal cortisol and prolactin response. Verified at 99.77–99.81%. Ideal pairing with CJC-1295.
GHRH analogue with Drug Affinity Complex for extended half-life. Verified at 99.71–99.78% across both vial sizes.
Body Protection Compound — 15 amino acid partial sequence of body protection compound. Verified at 99.66–99.80%.
Copper peptide tripeptide-1. Verified at 99.68–99.71% purity. Available in 50mg vials for extended protocols.
BPC-157 (10mg) + GHK-Cu (50mg) + TB-500 (10mg) — 70mg premium compound blend. COA-verified total purity 99.77%.
0.9% benzyl alcohol sterile water for reconstitution. 3mL multi-use vials compatible with all lyophilized peptide compounds. USP-grade.
29-gauge, 1mL insulin syringes. Sterile, individually wrapped, latex-free. Compatible with all reconstituted peptide compounds.
70% isopropyl alcohol prep wipes. Pre-saturated, sterile, individually wrapped. Essential for safe injection site preparation.
Compact thermoelectric mini fridge for peptide storage. Maintains 2–8°C for reconstituted compounds. Whisper-quiet, no vibration.
Everything to start: 10 insulin syringes, 50 alcohol wipes, and 2× bacteriostatic water vials. Bundled for convenience.
Cyclic heptapeptide melanocortin receptor agonist. Verified at 99.61% purity. 10mg vials.
44-amino acid GHRH analogue. FDA-approved sequence. Third-party purity verification in progress.
29-amino acid GHRH(1–29) fragment. Stimulates endogenous GH secretion. Third-party verification in progress.
Hexapeptide GHRP with strong GH-releasing activity. Synergistic with GHRH analogues. Verification in progress.
HGH fragment 177–191. Targets adipose tissue metabolism without IGF-1 elevation. Verification in progress.